Results 171 to 180 of about 114,251,227 (259)

Antibiotic‐mediated immune modulation in periodontitis

open access: yesPeriodontology 2000, EarlyView.
Abstract Periodontitis is a chronic inflammatory disease affecting the supporting structures of the teeth. Although initiated by dysbiotic microbial communities, its progression is largely driven by the host's uncontrolled inflammatory response. While antibiotics have conventionally been employed in periodontitis therapy for their antimicrobial ...
Lina J. Suárez   +6 more
wiley   +1 more source

Hepatitis A vaccine: what you need to know [Spanish]

open access: yes
Hepatits A vaccine: what you need to know [Spanish]Hepatitis A VIS \u2013 Spanish (10/15/21)spanish_hepatitis_a ...

core   +1 more source

Immunogenicity and safety of hepatitis A vaccine in liver and renal transplant recipients.

open access: yesJournal of Infectious Diseases, 1999
K. Stark   +6 more
semanticscholar   +1 more source

Health and Survival Impacts of Early Childhood Development Programmes: The Case of the Happy Child Programme in Brazil

open access: yesReview of Development Economics, EarlyView.
ABSTRACT This paper adds to the growing evidence on the impacts of early childhood development (ECD) programming by examining one of the world's largest home visitation programmes, the Happy Child Programme in Brazil, and its impacts on child vaccination and preventable death rates.
Raquel Tebaldi   +2 more
wiley   +1 more source

Immunological Efficacy of a Three-Dose Schedule of Hepatitis A Vaccine in HIV-Infected Adults: HEPAVAC Study

open access: yesJournal of Acquired Immune Deficiency Syndromes, 2008
O. Launay   +14 more
semanticscholar   +1 more source

Hepatitis A vaccine: what you need to know [Russian]

open access: yes
Hepatits A vaccine: what you need to know [Russian]Hepatitis A VIS \u2013 Russian (10/15/21)russian_hepatitis_a ...

core  

Hepatitis B in Organ Transplantation—Current Evidence and Clinical Gaps

open access: yesTransplant Infectious Disease, EarlyView.
ABSTRACT Over the past several decades there have been significant advances in nucleos(t)ide analogue (NA) antiviral therapy for hepatitis B virus (HBV) and global expansion of primary prevention through immunization. Despite this, HBV remains a leading cause of chronic liver disease globally, affecting over 250 million people.
Oscar A. Fernandez‐Garcia   +3 more
wiley   +1 more source

Hepatitis A vaccine associated with autoimmune hepatitis.

open access: yesWorld Journal of Gastroenterology, 2007
P. Berry, G. Smith-Laing
semanticscholar   +1 more source

Hepatitis A vaccine: what you need to know [Hatian Creole]

open access: yes
Hepatits A vaccine: what you need to know [Hatian Creole]Hepatitis A VIS - Haitian Creole (10/15/21)haitian_creole_hepatitis_a ...

core  

Viral Hepatitis A, B and C in Roraima, Brazilian Amazon: Epidemiological and Serological Profile, 2012–2023

open access: yesTropical Medicine &International Health, EarlyView.
ABSTRACT Introduction Viral hepatitis remains a major global public health challenge, with heterogeneous epidemiological patterns across geographic and socioeconomic contexts. In the Brazilian Amazon, evidence remains limited, particularly regarding long‐term trends.
Jamilla Karla Corrêa Reis   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy